ABLV vs BABA

ABLV's Piotroski F-Score of 4/9 indicates weak financial health, falling short of the stable threshold and signaling operational inefficiencies. The absence of an Altman Z-Score raises significant distress risk concerns, particularly given the company's negative ROE (-120.86%) and ROA (-11.31%), which reflect deep profitability erosion. Despite a modest price-to-book of 3.52 and a low price-to-sales of 0.30, the stock trades at a steep discount to its 52-week high, suggesting prolonged market skepticism. Revenue has declined sharply by 23.9% YoY, with no signs of recovery, and the company shows no dividend policy or analyst coverage. These factors collectively point to a high-risk, fundamentally weak entity with limited near-term upside.

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.